US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

ホーム
投資
株式
カナダ
CSE
QuantumCore Ltd (QNCR) 銘柄情報

QuantumCore Ltd (QNCR)

1.50

-0.05

( -3.23% )

更新日時： 03:27:55

QuantumCore Ltd (QNCR) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

1.50

( -3.23% )

買値

1.50

売値

1.58

出来高

39,505

1.41 日の範囲 1.60

1.00 52 週間の範囲 3.10

時価総額

前日終値

1.55

始値

1.60

時刻

最終取引時間

03:27:55

財務取引量

-

VWAP

-

平均取引量 (3 か月)

$ 91,979

発行済株式数

28,409,973

配当利回り

PER

-1.88k

1 株当たり利益 (EPS)

-0

歳入

-

純利益

-43.38k

QuantumCore Ltd. operates as a hardware partner to the global quantum computing industry. It designs and builds microchip sets engineered for cryogenic and superconducting environments. It provides the enabling “picks-and-shovels” hardware required to unlock the next stage of scalable quantum system... QuantumCore Ltd. operates as a hardware partner to the global quantum computing industry. It designs and builds microchip sets engineered for cryogenic and superconducting environments. It provides the enabling “picks-and-shovels” hardware required to unlock the next stage of scalable quantum systems. Its product cryogenic signal-processing chips are designed to improve qubit performance, enhance readout accuracy, and reduce thermal interference. The company is based in Toronto, Canada. 詳細を表示

セクター

-

業界

-

ウェブサイト

qncor.ca

本社

Toronto, Canada

設立

-

QuantumCore Ltd is listed in the sector of the Canadian Securities Exchange with ticker QNCR. The last closing price for QuantumCore was $1.55. Over the last year, QuantumCore shares have traded in a share price range of $ 1.00 to $ 3.10.

QuantumCore currently has 28,409,973 shares in issue. The market capitalisation of QuantumCore is $42.61 million. QuantumCore has a price to earnings ratio (PE ratio) of -1,877.93.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.3	-16.6666666667	1.8	1.8	1.41	45424	1.63452522	CS
4	-0.57	-27.5362318841	2.07	2.35	1.41	44467	1.85837553	CS
12	0.5	50	1	3.1	1	91485	2.06196441	CS
26	0.5	50	1	3.1	1	91485	2.06196441	CS
52	0.5	50	1	3.1	1	91485	2.06196441	CS
156	0.5	50	1	3.1	1	91485	2.06196441	CS
260	0.5	50	1	3.1	1	91485	2.06196441	CS

QNCR - Frequently Asked Questions (FAQ)

What is the current QuantumCore Ltd share price?

The current share price of QuantumCore Ltd is $ 1.50

How many QuantumCore Ltd shares are in issue?

QuantumCore Ltd has 28,409,973 shares in issue

What is the market cap of QuantumCore Ltd?

The market capitalisation of QuantumCore Ltd is CAD 42.61M

What is the 1 year trading range for QuantumCore Ltd share price?

QuantumCore Ltd has traded in the range of $ 1.00 to $ 3.10 during the past year

What is the PE ratio of QuantumCore Ltd?

The price to earnings ratio of QuantumCore Ltd is -1.88k

What is the registered address of QuantumCore Ltd?

The registered address for QuantumCore Ltd is 365 Bay St., Toronto, Ontario, M5H 2V1

What is the QuantumCore Ltd website address?

The website address for QuantumCore Ltd is qncor.ca

luckydude777

luckydude777 3分前

https://www.youtube.com/shorts/O8JiNHcI3jI

cottonmather

cottonmather 3分前

And that doesn't include all derivaives eom

MomsSpaghetti

MomsSpaghetti 4分前

Thanks Silver! Been a long ride. Looks like we are taking off. Expect even new comers to get a successful investment from this as well. The rest of the year has so many more catalysts. What a ride.

Cheers!

bubka

Wait, another offering and more dilution? You know how I feel about dilution, but this time I fully support it. Securing strong cash reserves is exactly what a developmental biotech with great trial results needs. You provided a fantastic summary of our current position. Thanks, and go DFTX

Doc328

The applicant’s claim that who drafted the SAP lacked experience in Alzheimer’s disease trial design and
analysis does not increase the credibility of the findings. The approach for analysing the data was
changed after the end of the study. The applicant openly admits problems with an

ergo sum

ergo sum 4分前

Bought 3 of these today.

Investor2014

Investor2014 4分前

Yes and note too that Anavex did not request scientific advise from the CHMP during the application process!!!

jjjjjjjj

jjjjjjjj 4分前

https://ih.advfn.com/stock-market/USOTC/medical-marijuana-pk-MJNA/trades?_gl=1*1kzkgjy*_gcl_au*MTI1NDQyNTM1NS4xNzMxNjA2NTY3

IT IS DAMN IF IT GOES UP, DAMN IF IT GOES DOWN!which is it??? Let it flow freely . The harder the push, the harder the pullback. ROME WAS NOT BUILT IN ONE DAY. S

WhereDaStocksAt

WhereDaStocksAt 5分前

Doubled my position at low .01s. If I die, I die lol. Dust or Gold. Willing to double again at .0080s but that's it LOL.

Jcbaby1

Jcbaby1 6分前

CSAI on watch for possible squeeze play

PickStocks

PickStocks 6分前

Rumor was JPM hits 300….a distribution happens…just 50.00 for 60 days….but neither happened

SilverTonguedSun

SilverTonguedSun 6分前

Great take and eloquently put, cheers to the future of this company and the sector as a whole! 🍻

Investor2014

Investor2014 6分前

No surprises to me, except that Anavex had applied for approval only for SIGMAR1 wild type patients.

The application relied on one pivotal trial that failed its primary objective. Claimed positive endpoint results were considered non-confirmatory because of the trial failure, lack of

santafe2

santafe2 6分前

I've followed Jeremy Grantham since the early 1990s. He's sometimes referred to as a perma-bear but he's simply a more conservative investor. He's also called the three most significant market downturns in the last 40 years. He's also calling this one; the AI bubble. Since I began taking this bubble

Trum

SCAM... proven SCAM... pump and dump winding down... maybe get back in at .0001-3 range and hold for a year +... maybe ...

Whalatane

Whalatane 6分前

Thx ...but its more confidence in the hedge funds backing UNCY .
They're in it to make as much $ as fast as possible ...are they at about 40% of ownership ?? will chk .
They will be all about licensing or out right sale ...although I expect them to wait to see if TDAPA is extended ou

doccjc

All these share price predictions post IDE approval seem fairly low imo . Let’s not forget IsoPet nearing profitability , India and other future international trials ? And PrecisionGel licensing potential. Not a one trick pony . IDE approval should get the ball rolling

i_like_bb_stock

i_like_bb_stock 8分前

Overwatch

Overwatch 8分前

If I didn't like a ticker the last thing I would do is spend the entire f"n day here posting... Cover your short positions assholes...

MarketMindset

MarketMindset 9分前

Kobrea Confirms Copper-Gold Porphyry System at El Perdido – Core Still Untested, System Strengthening at Depth

Posted on behalf of Kobrea Copper Corp. - First drill campaign. Porphyry system confirmed. Most of the target still untested.

Kobrea's inaugural program at El

Overwatch

Overwatch 9分前

This ticker needs a GME F YOU...

quigley24

quigley24 9分前

when the audit comes out......it will be WORTH THE WAIT

Jcbaby1

Jcbaby1 9分前

CSAI about to make its move

Trooperstocks

Trooperstocks 10分前

$ILLR Triller Group (Nasdaq: ILLR): The Reverse Split Is Not the Story — Execution, Recapitalization and Shareholder Value Are
June 25 2026

Following today’s announcement by Triller Group Inc. (Nasdaq: ILLR) regarding its SPCX-linked strategic treasury transaction, Wing-Fai Ng

Cambreau

Cambreau 10分前

Been 45 days since shares have been updated. Wonder how close this is to A.S. being maxed out ?

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。